Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

MedMira Receives Investigational Testing Authorizations for Multiplo(R) TP/HIV Self-Test and Non-Professional Use Applications
MedMira Receives Investigational Testing Authorizations for Multiplo(R) TP/HIV Self-Test and Non-Professional Use Applications

Halifax, Nova Scotia, 21st of January, 2025 - MedMira Inc. (MedMira) (TSXV: MIR) announced today that it has received Investigational Testing Authorizations (ITAs) from Health Canada to begin

MedMira erhält Prüfgenehmigungen für Multiplo(R) TP/HIV-Selbsttest und Anwendungen für den nicht-professionellen Gebrauch
MedMira erhält Prüfgenehmigungen für Multiplo(R) TP/HIV-Selbsttest und Anwendungen für den nicht-professionellen Gebrauch

Halifax, Nova Scotia, 21. Januar 2025 - MedMira Inc. (MedMira) (TSXV: MIR) gab heute bekannt, dass das Unternehmen von Health Canada die Investigational Testing Authorizations (ITAs)

Sirona Biochem Showcases TFC-1326 in Stonegate Healthcare's Landmark Report
Sirona Biochem Showcases TFC-1326 in Stonegate Healthcare's Landmark Report
Microsoft Word - Stonegate Healthcare Publishes Research Report

January 15, 2025 – Vancouver, British Columbia – Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) is excited to

Sirona Biochem präsentiert TFC-1326 in wegweisendem Bericht von Stonegate Healthcare
Sirona Biochem präsentiert TFC-1326 in wegweisendem Bericht von Stonegate Healthcare
Microsoft Word - Stonegate Healthcare Publishes Research Report

15. Januar 2025 - Vancouver, British Columbia / IRW-Press / Sirona Biochem Corp. (TSX-V: SBM) (FWB: ZSB) (OTC: SRBCF) freut sich